Literature DB >> 31644309

Association Study Reveals One Susceptibility Locus with Vitiligo in the Chinese Han Population.

Xianfa Tang1,2,3, Fang Fang1,2,3, Jingjing Yang1,2,3, Xiaodong Zheng2,3, Min Fan1, Liyun Wang1, Anping Zhang1,2,3.   

Abstract

Objective: The purpose of this study was to investigate associations between the 14 reported loci (from a meta-analysis of genome-wide association studies [GWAS] in the Caucasian population) and vitiligo in the Chinese Han population. Materials and
Methods: In this study 14 single nucleotide polymorphisms (SNPs) at 14 different genetic loci were evaluated for their association with viteligo in a Chinese Han cohort, including 1472 cases and 1472 controls of by using the Sequenom MassArray iPLEX1 system. A Bonferroni adjustment was used for multiple comparisons and pBonferroni <0.0056 was considered statistically significant.
Results: The T allele of the locus within the FBXO45-NRROS gene (3q29) was significantly associated with vitiligo (odds ratio = 1.22, 95% confidence interval: 1.10-1.36, p = 0.0001). Association at the genotype level was strong (p = 0.0007). The other SNPs were not associated with vitiligo (pBonferroni >0.0056).
Conclusion: A SNP at the rs6583331 locus 3q29 is associated with the susceptibility of vitiligo in the Chinese Han population, which suggests that there is a common genetic factor predisposing to the development of vitiligo in the Chinese and Caucasian populations.

Entities:  

Keywords:  FBXO45; NRROS; SNPs; association study; susceptibility gene; vitiligo

Mesh:

Substances:

Year:  2019        PMID: 31644309     DOI: 10.1089/gtmb.2019.0129

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  2 in total

1.  Validation of Susceptibility Loci for Vitiligo Identified by GWAS in the Chinese Han Population.

Authors:  Lu Cheng; Bo Liang; Xian-Fa Tang; Xin-Ying Cai; Hui Cheng; Xiao-Dong Zheng; Jie Zheng; Meng-Wei Wang; Jun Zhu; Fu-Sheng Zhou; Pan Li; Feng-Li Xiao
Journal:  Front Genet       Date:  2020-12-03       Impact factor: 4.599

Review 2.  FBXO45 is a potential therapeutic target for cancer therapy.

Authors:  Min Lin; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Cell Death Discov       Date:  2020-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.